Patent · US Active

Isoserine derivatives for use as coagulation factor IXa inhibitors

US8097758B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Henning Steinhagen · Pocking, DE
Markus Follmann
Jochen Goerlitzer · Frankfurt am Main, DE
Herman Schreuder · Frankfurt am Main, DE

Key dates

Filing date	Mar 9, 2009
Grant date	Jan 17, 2012
Priority date	—
Expiry date	Jul 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2529/40
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to the compounds of formula (I)having antithrombotic activity which especially inhibit blood clotting factor IXa, to methods for producing the same and to the use thereof as drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.